The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia ...

New preclinical and translational findings position DNase I as a potentially transformative adjunct therapy for CAR-T ...

With the publication of the long-term data from the RELAZA2 study, a research program developed over many years by Dresden ...

Caroline Kennedy's daughter, Tatiana Schlossberg, died at age 35 in December 2025 following a battle with cancer, after ...

Treatment with so-called BTK inhibitors has improved the prognosis for people with chronic lymphocytic leukemia (CLL). At the same time, these drugs affect the immune system and may cause side effects ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced publication of a peer-reviewed study in Modern Pathology showing that optical genome mapping (OGM) detected genomic abnormalities in 97.8% of ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical ...

A retrospective study evaluates the effectiveness of CD19 CAR T-cell therapy in relapsed/refractory B-cell acute lymphoblastic leukemia with extramedullary or CNS disease.

Thousands are flying abroad for stem cell treatments that cost a fortune and lack evidence. Here’s what’s real.

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that it will present data on CTA313, its investigational ...

New Berlin 9-year-old Taylor Daniels used painting to cope with leukemia, later helping Paintings for Pediatrics raise money ...

Researchers suppressed two proteins in order to enhance NK cells’ cancer-fighting power. The strategy killed cancer cells and ...